New insights into the pathogenesis and therapy of sepsis and septic shock.
Llewelyn
M
M
Department of Infectious Diseases and Microbiology, Imperial College School of Medicine, London, England.
Cohen
J
J
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000494:pharmacology; D001777:Blood Coagulation / Q000187:drug effects; D017326:Clinical Trials, Phase III as Topic; D016207:Cytokines / Q000627:therapeutic use; D006090:Gram-Negative Bacteria / Q000187:drug effects* / Q000472:pathogenicity; D006094:Gram-Positive Bacteria / Q000187:drug effects* / Q000472:pathogenicity; D006801:Humans; D008070:Lipopolysaccharides / Q000037:antagonists & inhibitors / Q000378:metabolism*; D018805:Sepsis / Q000188:drug therapy / Q000382:microbiology / Q000401:mortality; D012772:Shock, Septic / Q000188:drug therapy / Q000382:microbiology / Q000401:mortality
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D016207:Cytokines; D008070:Lipopolysaccharides